𝔖 Bobbio Scriptorium
✦   LIBER   ✦

FBN1 mutations in patients with descending thoracic aortic dissections

✍ Scribed by Ariel Brautbar; Scott A. LeMaire; Luis M. Franco; Joseph S. Coselli; Dianna M. Milewicz; John W. Belmont


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
82 KB
Volume
152A
Category
Article
ISSN
1552-4825

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Aortic aneurysm and dissection cause significant morbidity and mortality. There are several known single gene disorders that predispose to isolated aortic disease and eventually aneurysm and dissection. FBN1 mutations are associated with multiple clinical phenotypes, including Marfan syndrome (MFS), MASS phenotype, and familial ectopia lentis, but rarely with isolated aortic aneurysm and dissection. In this report, we describe three patients who presented with primary descending thoracic aortic dissection and who were found to have an FBN1 mutation. None of the patients fulfilled clinical criteria for the diagnosis of MFS, and all had few or none of the skeletal features typical of the condition. Two patients had a history of long‐term hypertension, and such a history was suspected in the third patient. These observations suggest that some individuals with FBN1 mutations have significant aortic disease involvement of other systems that is typical of FBN1 mutation‐related syndromes. Superimposed risk factors, such as hypertension, may weaken the aortic wall and eventually lead to aortic dissection. Given that the cost continues to decrease, we suggest that diagnostic DNA sequencing for FBN1 mutations in patients with thoracic aortic aneurysms and dissection may be a practical clinical step in evaluating such patients and at‐risk family members. Β© 2010 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Identification of 9 novel FBN1 mutations
✍ Alice Abd El-Aleem; Matthias Karck; Axel Haverich; JΓΆrg Schmidtke; Mine Arslan-K πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 20 KB πŸ‘ 2 views

We report 9 new mutations in German patients presenting with classical Marfan syndrome. All mutations occur in exons with calcium-binding (cb) epidermal growth factor-like (EGF) domains. Five mutations are missense involving exons 12, 27, 30, 44, and 52 with the resultant substitution of cysteine by